Avadel Pharmaceuticals PLC (NAS:AVDL)
$ 13.945 0.295 (2.16%) Market Cap: 1.34 Bil Enterprise Value: 1.24 Bil PE Ratio: 0 PB Ratio: 19.10 GF Score: 43/100

Q3 2019 Avadel Pharmaceuticals PLC Earnings Call Transcript

Nov 12, 2019 / 01:30PM GMT
Release Date Price: $5 (+2.04%)
Operator

Greetings. Welcome to Avadel Third Quarter 2019 Earnings Call. (Operators Instructions) Please note, this conference is being recorded.

I will now turn the conference over to your host, Mr. Michael Kanan, Chief Financial Officer. Please go ahead.

Michael Kanan

Good morning and thank you for joining us on our conference call. This morning, we issued our third quarter 2019 financial results news release. The release can be accessed on our website at avadel.com.

As a reminder, before we begin, the following presentation includes a number of matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. These risks include that products in the development stage may not achieve scientific objectives or milestones or meet stringent regulatory requirements, uncertainties regarding market acceptance of products and the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot